Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Radiation Therapy for Prostate Cancer.

Kamran SC, D'Amico AV.

Hematol Oncol Clin North Am. 2020 Feb;34(1):45-69. doi: 10.1016/j.hoc.2019.08.017. Epub 2019 Oct 28. Review.

PMID:
31739952
2.

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Créhange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT.

Cancer Radiother. 2014 Oct;18(5-6):524-34. doi: 10.1016/j.canrad.2014.07.153. Epub 2014 Sep 2. Review. Erratum in: Cancer Radiother. 2014 Dec;18(8):806.

PMID:
25192626
3.

Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.

Battaglia A, De Meerleer G, Tosco L, Moris L, Van den Broeck T, Devos G, Everaerts W, Joniau S.

Eur Urol Oncol. 2019 Mar;2(2):174-188. doi: 10.1016/j.euo.2018.09.005. Epub 2018 Oct 9. Review.

PMID:
31017094
4.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

Martinez AA, Demanes DJ, Galalae R, Vargas C, Bertermann H, Rodriguez R, Gustafson G, Altieri G, Gonzalez J.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1322-31.

PMID:
16029788
5.

Evolution of definitive external beam radiation therapy in the treatment of prostate cancer.

Daly T.

World J Urol. 2019 Mar 8. doi: 10.1007/s00345-019-02661-6. [Epub ahead of print] Review.

PMID:
30850855
6.

A review of salvage treatment options for disease progression after radiation therapy for localized prostate cancer.

Steele EM, Holmes JA.

Urol Oncol. 2019 Sep;37(9):582-598. doi: 10.1016/j.urolonc.2019.04.030. Epub 2019 May 24. Review.

PMID:
31133370
7.

Recent advances in radiation oncology: multimodal targeting of high risk and recurrent prostate cancer.

Kwok Y, Kaiser A, Rice SR, Cohen R, Mishra M.

Curr Opin Oncol. 2018 May;30(3):165-171. doi: 10.1097/CCO.0000000000000440. Review.

PMID:
29465428
8.

Pushing the limits of radiation therapy for prostate cancer: where do we go next?

Mishra MV, Showalter TN.

Semin Oncol. 2013 Jun;40(3):297-307. doi: 10.1053/j.seminoncol.2013.04.005. Review.

PMID:
23806495
9.

Stereotactic ablative body radiotherapy in patients with prostate cancer.

Loblaw A, Liu S, Cheung P.

Transl Androl Urol. 2018 Jun;7(3):330-340. doi: 10.21037/tau.2018.01.18. Review.

10.

Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Woodrum DA, Kawashima A, Gorny KR, Mynderse LA.

Abdom Radiol (NY). 2016 May;41(5):877-88. doi: 10.1007/s00261-016-0681-3. Review.

11.

Hypofractionation for clinically localized prostate cancer.

Hickey BE, James ML, Daly T, Soh FY, Jeffery M.

Cochrane Database Syst Rev. 2019 Sep 3;9:CD011462. doi: 10.1002/14651858.CD011462.pub2.

PMID:
31476800
12.

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer.

Kim J, Park JS, Ham WS.

Investig Clin Urol. 2017 Sep;58(5):307-316. doi: 10.4111/icu.2017.58.5.307. Epub 2017 Aug 8. Review.

13.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
14.

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P.

Eur Urol. 2017 Apr;71(4):618-629. doi: 10.1016/j.eururo.2016.08.003. Epub 2016 Aug 25.

PMID:
27568654
15.

Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.

Kuru TH, Roethke MC, Seidenader J, Simpfendörfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA.

J Urol. 2013 Oct;190(4):1380-6. doi: 10.1016/j.juro.2013.04.043. Epub 2013 Apr 19.

PMID:
23608676
16.

What is the best way to radiate the prostate in 2016?

Moon DH, Efstathiou JA, Chen RC.

Urol Oncol. 2017 Feb;35(2):59-68. doi: 10.1016/j.urolonc.2016.06.002. Epub 2016 Jul 6. Review.

PMID:
27395453
17.

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, Pomper MG, DeWeese TL, Dicker A, Eisenberger M, Tran PT.

BMC Cancer. 2017 Jun 29;17(1):453. doi: 10.1186/s12885-017-3455-6.

18.

Progress and controversies: Radiation therapy for prostate cancer.

Martin NE, D'Amico AV.

CA Cancer J Clin. 2014 Nov-Dec;64(6):389-407. doi: 10.3322/caac.21250. Epub 2014 Sep 18. Review.

19.

Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.

Baumann BC, Baumann JC, Christodouleas JP, Soffen E.

Brachytherapy. 2017 Mar - Apr;16(2):291-298. doi: 10.1016/j.brachy.2016.12.011. Epub 2017 Jan 27.

PMID:
28139422
20.

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.

Maenhout M, Peters M, van Vulpen M, Moerland MA, Meijer RP, van den Bosch MAAJ, Nguyen PL, Frank SJ, van der Voort van Zyp JRN.

Technol Cancer Res Treat. 2017 Dec;16(6):1194-1201. doi: 10.1177/1533034617741797. Epub 2017 Dec 5.

Supplemental Content

Support Center